267 Participants Needed

Thrive Intervention for Mental Illness

(THRIVE-SMI Trial)

JM
KA
EB
Overseen ByErin Babe, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Pennsylvania
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial tests a new approach called the THRIVE Intervention to assist people with serious mental illnesses after hospital discharge. It aims to determine if this method, which includes home care visits and regular check-ins, reduces emergency room visits and readmissions more effectively than usual care. Participants must be insured by Medicaid, reside in Pennsylvania, and have been recently hospitalized. The study will compare the results of those using the THRIVE method to those receiving standard discharge care. As an unphased trial, it offers a unique opportunity to contribute to innovative care strategies that could improve post-hospitalization outcomes.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What prior data suggests that the THRIVE clinical pathway is safe for Medicaid-insured individuals with serious mental illness?

Research shows that the Thrive Intervention helps people with Medicaid transition from hospital care to home care. This program aims to improve care for those with serious mental illnesses by supporting them immediately after hospital discharge.

While specific safety data for the Thrive Intervention isn't detailed, the treatment relies on proven methods, indicating effectiveness and safety in similar situations. The Thrive program helps patients manage their health better, suggesting it is well-tolerated.

Although this trial doesn't have a specific phase, safety remains a top priority. Programs like Thrive undergo testing to ensure they don't cause harm and aim to improve patient outcomes. Those interested in this trial should consult a healthcare provider to understand its benefits for their situation.12345

Why are researchers excited about this trial?

Researchers are excited about the Thrive Intervention for mental illness because it offers a new approach to post-discharge care. Unlike the usual care where patients are simply discharged home without additional support, the Thrive Intervention provides a 1-month intensive case management and care coordination. This personalized support aims to bridge the gap between hospital care and home, potentially reducing relapse rates and improving overall outcomes for patients. By focusing on continuity of care, Thrive could significantly enhance the recovery process for individuals with mental illness.

What evidence suggests that the THRIVE Intervention is effective for mental illness?

This trial will compare the THRIVE Intervention with usual care. Research has shown that the THRIVE Intervention can assist Medicaid recipients transitioning from the hospital to their home. Early results suggest that this program increases home care access and reduces hospital readmissions within 30 days, as well as emergency room visits. By closely managing and coordinating care, the program appears to help patients, including those with serious mental health issues, better manage their health post-discharge. This evidence-based care model is designed to support individuals needing extra assistance during this transition period.13467

Who Is on the Research Team?

JM

Jacqueline M Brooks Carthon, PhD,RN

Principal Investigator

University of Pennsylvania

Are You a Good Fit for This Trial?

This trial is for adults with Medicaid insurance in Pennsylvania who have been hospitalized and agree to home care. It's designed to help those, especially with serious mental illness, transition after hospitalization.

Inclusion Criteria

I am covered by Medicaid.
Residing in the state of Pennsylvania
Experienced a hospitalization at study hospital
See 1 more

Exclusion Criteria

I am under 18 years old.

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive intensive post-discharge case management and care coordination through the THRIVE intervention

4 weeks
Weekly case conferences

Follow-up

Participants are monitored for safety and effectiveness after treatment, including tracking of readmissions and ED visits

30 days

Qualitative Study

Interviews conducted to gather perceptions of the THRIVE clinical pathway and identify barriers and facilitators

18 months

What Are the Treatments Tested in This Trial?

Interventions

  • Thrive Intervention
Trial Overview The THRIVE clinical pathway is being tested. It includes a home care nurse visit within 48 hours of discharge and ongoing care coordination for 30 days, aiming to reduce readmissions and emergency visits compared to standard care.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: THRIVE InterventionExperimental Treatment1 Intervention
Group II: Usual CareActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pennsylvania

Lead Sponsor

Trials
2,118
Recruited
45,270,000+

Agency for Healthcare Research and Quality (AHRQ)

Collaborator

Trials
415
Recruited
6,777,000+

Published Research Related to This Trial

The American Association of Community Psychiatrists has developed guidelines aimed at improving continuity of care for individuals with severe behavioral health issues, emphasizing the importance of consistent treatment engagement.
These guidelines provide a framework for creating transition plans and evaluating service quality, which can help address the common problem of fragmented care in mental health services.
American Association of Community Psychiatrists' principles for managing transitions in behavioral health services.Sowers, WE., Rohland, B.[2007]
The transition to Tennessee's TennCare Partners program led to a significant increase in the odds of patients losing continuity of antipsychotic therapy, with a multivariate odds ratio of 1.18, indicating a higher risk of missed treatment days.
Patients requiring more intensive treatment, such as depot injections or those with a history of hospitalization for psychosis, experienced the most pronounced negative effects, with a mean reduction of 14.4 days in antipsychotic therapy during follow-up.
Effect of a mental health "carve-out" program on the continuity of antipsychotic therapy.Ray, WA., Daugherty, JR., Meador, KG.[2019]
The Bridge intervention, a peer-led health navigator program, significantly reduced emergency room visits among 144 individuals with serious mental illnesses, showing its effectiveness in improving healthcare access.
While the intervention did not affect overall inpatient or outpatient service use, the reduction in emergency room visits suggests that it may help individuals manage their health more effectively and avoid crisis situations.
Service Use by Medicaid Recipients With Serious Mental Illness During an RCT of the Bridge Peer Health Navigator Intervention.Kelly, EL., Hong, B., Duan, L., et al.[2021]

Citations

Transitional care innovation for Medicaid-insured individualsEarly results from year 1 of the THRIVE clinical pathway suggests increasing home care referrals and reductions in 30-day readmission and ED use ...
Improvements in Transitional Care Among Medicaid- ...Background: The Thrive program is an evidenced-based care model for Medicaid-insured adults in the hospital-to-home transition.
Transitional Care Support for Medicaid-Insured Patients ...Objective: This study aimed to (1) engage staff and community advisors in participatory implementation processes to adapt the Thrive clinical ...
Improving Care Transitions for Medicaid Insured ...This study aims to evaluate the THRIVE clinical pathway at HUP, focusing on supporting Medicaid-insured individuals, including those with serious mental illness ...
Transitional Care Support for Medicaid-Insured Patients ...Transitional Care Support for Medicaid-Insured Patients With Serious Mental Illness: Protocol for a Type I Hybrid Effectiveness-Implementation ...
Transitional Care Support for Medicaid-Insured Patients ...The Thrive clinical pathway provides transitional care support for patients insured by Medicaid with multiple chronic conditions by focusing on ...
Implementation and Evaluation of A Health Innovation to ...The THRIVE Clinical Pathway is a standardized transitional care clinical pathway that supports Medicaid insured or Medicaid eligible individuals following ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security